63. Wooltorton E. Accutane (iso<strong>tretinoin</strong>) and psychiatric ad<strong>ve</strong>rse effects. CMAJ 2003;168(1):66. 64. Cunliffe WJ, Goulden V. Phototherapy and acne vulgaris. Br J Dermatol 2000;142:855-6. 65. Korkut C, Piskin S. Benzoyl peroxide, adapalene, and their combination in the treatment of acne vulgaris. J Dermatol 2005;32:169-73. 66. Peker M, Taştan HB, Arca E, Erbil AH, Gür AR. Akne vulgariste <strong>topikal</strong> <strong>eritromisin</strong>, tetrasiklin <strong>ve</strong> klindamisinin etkinliği. TÜRKDERM 2004;38:199-207. 67. Ergin Ç, Ergin Ş, Yavrucuoğlu E, Kaya C. Akne hastalarında propionibacterium acnes <strong>ve</strong> <strong>eritromisin</strong> direnci: üç yıllık prospektif analiz. TÜRKDERM 2001;35:308-10. 68. Grosshans E, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel <strong>ve</strong>rsus <strong>tretinoin</strong> 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139(Suppl 52):26-33. 69. Ellis CN, Millikan LE, Smith EB, Chalker DM, Swinyer LJ, Katz IH et al. Comparison of adapalene 0.1% solution and <strong>tretinoin</strong> 0.025% gel in the topical treatment of acne vulgaris Br J Dermatol 1998;(Suppl 52):41-7. 70. Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan A, Katz HI et al. A comparison of the efficacy and safety of adapalene gel 0.1% and <strong>tretinoin</strong> gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996;34(3):482-5. 71. Berger R, Barba A, Fleischer A, Leyden JJ, Lucky A, Pariser D et al. A double-blinded, randomized, <strong>ve</strong>hicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of <strong>tretinoin</strong> gel microsphere 0.04% in the treatment of acne vulgaris in adults. Cutis 2007;80(2):152-7. 72. Korting HC, Braun-Falco O. Efficacy and tolerability of combined topical treatment of acne vulgaris with <strong>tretinoin</strong> and erythromycin in general practice. Drugs Exp Clin Res 1989;15(9):447-51. 73. Kreusch J, Bextermöller R. Efficacy and tolerability of a topical erythromycin/<strong>tretinoin</strong> combination preparation in acne treatment: post-marketing sur<strong>ve</strong>illance study involving o<strong>ve</strong>r 6500 patients. Curr Med Res Opin 2000;16(1):1-7. 74. Gupta AK, Lynde CW, Kunynetz RA, Amin S, Choi K, Goldstein E. A randomized, double-blind, multicenter, parallel group study to compare relati<strong>ve</strong> efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% <strong>tretinoin</strong>/erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg 2003;7(1):31-7. 75. Mills OH Jr, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and <strong>tretinoin</strong>. Acta Derm Venereol 1978;58(6):555-7. 54
EKLER 55
- Page 1 and 2:
T.C. TRAKYA ÜNİVERSİTESİ TIP FA
- Page 3 and 4:
İÇİNDEKİLER GİRİŞ VE AMAÇ .
- Page 5 and 6:
GİRİŞ VE AMAÇ Akne vulgaris, pi
- Page 7 and 8: ETYOLOJİ VE PATOGENEZ Akne vulgari
- Page 9 and 10: Normal bir follikülde keratinositl
- Page 11 and 12: sitokinlerle devam eder. Akne vulga
- Page 13 and 14: DERECELENDİRME Akne hastasında uy
- Page 15 and 16: ulunmuştur (50). Ayrıca yapılan
- Page 17 and 18: Tablo 2. Akneiform lezyonlara yol a
- Page 19 and 20: Tablo 3. Akne tedavisinde kullanıl
- Page 21 and 22: e) Retinaldehit: Keratinositlerdeki
- Page 23 and 24: deri florasında değişiklik ve di
- Page 25 and 26: iyolojik olarak aktif androjenleri
- Page 27 and 28: soruldu. Bu bulgular yok=0, hafif=1
- Page 29 and 30: Hastalık süresi medyanı, çalı
- Page 31 and 32: Tablo 8. T grubunda tedavi süresin
- Page 33 and 34: istatistiksel olarak anlamlı orand
- Page 35 and 36: Hasta Sayısı 45 40 35 30 25 20 15
- Page 37 and 38: Hasta Sayısı 40 35 30 25 20 15 10
- Page 39 and 40: Hasta Sayısı 50 45 40 35 30 25 20
- Page 41 and 42: Şekil 18 ve 19’da eritromisin %4
- Page 43 and 44: Şekil 22 ve 23’te eritromisin+tr
- Page 45 and 46: Bernstein ve Shalita (15), 348 hast
- Page 47 and 48: tüm lezyonlar üzerine etkisi, pla
- Page 49 and 50: eritromisin+%0.025 tretinoin kombin
- Page 51 and 52: ÖZET Akne vulgaris, yüz, sırt, g
- Page 53 and 54: We determined that both tretinoin a
- Page 55 and 56: 11. Cunliffe WJ, Holland DB, Jeremy
- Page 57: 45. Witkowski JA, Parish LC. The as
- Page 61 and 62: EK 2 BİLGİLENDİRİLMİŞ OLUR FO
- Page 63 and 64: Olgu No: Prot. No: İsim: Yaş: Cin
- Page 65: EK 4 Hastaların Demografik Özelli